BioSpace News Archive

FDA

Novo Nordisk Wins FDA Approval for Mealtime Insulin Treatment for Children

The company said Fiasp is the “first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation.”

January 7, 2020
·
2 min read
·
Alex Keown
BioMidwest

In Lab Mice, Nanotechnology Helps Clear Late-Stage Sepsis

Researchers at Ohio State University are using nanotechnology to boost the body’s ability to fight sepsis, a life-threatening condition that results from the body’s extreme reaction to infection.

January 7, 2020
·
2 min read
·
Alex Keown
Drug Development

Merck’s Keytruda Shows Mixed Results in Lung Cancer Study

The study met one of its dual primary endpoints, progression-free survival, but missed the other endpoint, overall survival.

January 7, 2020
·
2 min read
·
Mark Terry
Policy

Another Scientist in Court Regarding Stolen GSK Intellectual Property

A Chinese scientist living abroad who has been accused of accepting stolen intellectual property to benefit a pharma startup in China has been extradited to the United States.

January 7, 2020
·
2 min read
·
Alex Keown
Genetown

Overview: CRISPR Technology Headed to Clinical Trials

Although much of the recent attention to CRISPR gene editing has been negative, CRISPR still remains one of the great hopes for treating diseases.

January 7, 2020
·
3 min read
·
Mark Terry
Biotech Bay

Harnessing the Body’s Own Protein Waste Removal System to Drug the ‘Undruggable’

How do you catch just one kind of fish in a sea of similar fish? That’s the question being answered by researchers at Nurix, except they aren’t catching fish – they are ‘catching’ proteins in your body.

January 7, 2020
·
8 min read
·
Chelsea Weidman Burke
Drug Development

Apellis’ PNH Drug Beats Alexion’s Soliris in Phase III Trial

Apellis Pharmaceuticals announced that its pegcetacoplan beat out Alexion Pharmaceuticals’ Soliris in its Phase III PEGASUS study in adults with paroxysmal nocturnal hemoglobinuria.

January 7, 2020
·
3 min read
·
Mark Terry
Business

AstraZeneca and MiNA Partner to Tackle saRNAs for Metabolic Diseases

MiNA said the collaboration will combine its “expertise in the discovery and development of saRNA therapeutics” with AstraZeneca’s experience in “identifying and bringing breakthrough treatments to patients with metabolic diseases.”

January 7, 2020
·
2 min read
·
Alex Keown
Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

Sequana Medical NV announces that the first patient has been enrolled in the first-in-human repeated dose study of alfapump DSR for the treatment of diuretic-resistant heart failure patients.

January 7, 2020
·
9 min read
Pharm Country

BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week

BrainStorm Cell Therapeutics Inc. announced that Chaim Lebovits, President and Chief Executive Officer, will provide a corporate overview at the 2020 Biotech Showcase, being held on January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco, California.

January 7, 2020
·
5 min read